RGS 0.00% 12.0¢ regeneus ltd

Proavctive half year write up, page-3

  1. 4,884 Posts.
    lightbulb Created with Sketch. 2
    Slide 7 in the latest presentation states this about AGC's aspirations:
      "Ambition and resources dedicated to supply global market"

    I think if the STEP trial results are positive, AGC will want to lock in Progenza and take it global for OA and other inflammatory areas. More $$ for RGS then, upfront licensing and royalty streams etc. for each market, would it be a global deal?
 
watchlist Created with Sketch. Add RGS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.